Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more
Neuroone Medical Technologies Corp (NMTC) - Total Liabilities
Latest total liabilities as of September 2025: $3.71 Million USD
Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $3.71 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Neuroone Medical Technologies Corp - Total Liabilities Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Neuroone Medical Technologies Corp Competitors by Total Liabilities
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MPM Corpóreos S.A
SA:ESPA3
|
Brazil | R$1.39 Billion |
|
Rockfields Property Indonesia Pt
JK:ROCK
|
Indonesia | Rp135.93 Billion |
|
FNC ADD CULTURE. Co. Ltd
KQ:063440
|
Korea | ₩5.94 Billion |
|
PBA Holdings Bhd
KLSE:5041
|
Malaysia | RM991.27 Million |
|
Solnaberg Property AB
ST:SOLNA
|
Sweden | Skr734.09 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $3.71 Million | -18.36% |
| 2024-09-30 | $4.55 Million | +146.11% |
| 2023-09-30 | $1.85 Million | -42.58% |
| 2022-09-30 | $3.22 Million | +132.43% |
| 2021-09-30 | $1.38 Million | -48.60% |
| 2020-09-30 | $2.69 Million | +52.16% |
| 2019-09-30 | $1.77 Million | -61.64% |
| 2018-09-30 | $4.61 Million | +351.02% |
| 2017-09-30 | $1.02 Million | +1127.83% |
| 2016-09-30 | $83.33K | +134.11% |
| 2015-09-30 | $35.59K | +23.14% |
| 2014-09-30 | $28.91K | +57.48% |
| 2013-09-30 | $18.36K | 0.00% |
| 2012-09-30 | $18.36K | +7.16% |
| 2011-09-30 | $17.13K | +27.33% |
| 2010-09-30 | $13.45K | -- |